Not only can CRP levels predict COVID-19-associated severe pneumonia early [23], but they were also shown to be elevated in patients with a poor COVID-19 prognosis, in patients who dies from COVID-19-related causes, and in patients with additional COVID-19-related radiological lesions and tissue damage [22, 23]. This evidence concerns the gene CRP and COVID-19.